Home » Topics » Regulatory

Regulatory
RSS

Chugai Pharma files for new indication of Pegasys

Jan. 27, 2011

TPIAO approved in China for idiopathic thrombocytopenic purpura

Jan. 26, 2011

FDA approves Viibryd for major depressive disorder

Jan. 25, 2011

New osteoporosis drug Edirol approved in Japan

Jan. 21, 2011

New indication for Lucentis in E.U. for vision loss in diabetic macular edema

Jan. 11, 2011

FDA extends label for Actemra

Jan. 10, 2011

FDA approves Tibotec's Intelence 200-mg formulation

Jan. 4, 2011

FDA approves Amturnide, a triple-combination pill, to treat high blood pressure

Dec. 24, 2010

European approval of Brilique for prevention of atherothrombotic events

Dec. 10, 2010

FDA approves Vyvanse for ADHD in adolescents

Nov. 17, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Flow Neuro wins FDA nod for at-home device for depression
BioWorld MedTech
Flow Neuroscience AB received U.S. FDA 510(k) approval for its Flow at-home brain-stimulation device to treat major depressive disorder. The wearable headset uses...